BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 Guidance

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $115 at Evercore ISI

August 6, 2024 5:02 AM EDT

Evercore ISI analyst Cory Kasimov raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $115.00 (from $113.00) while maintaining a Outperform rating.

The analyst comments "BMRN printed an encouraging 2Q beat-and-raise w/ solid progress for Voxzogo and long-awaited strategic direction not to mention... More